Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT00216411
Registration number
NCT00216411
Ethics application status
Date submitted
13/09/2005
Date registered
22/09/2005
Date last updated
29/07/2019
Titles & IDs
Public title
Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity of the Arm
Query!
Scientific title
A Prospective Phase IV, Multicentre, Placebo-controlled Study to Demonstrate Changes in the Quality of Life Following DYSPORT Intramuscular Injection in the Treatment of Upper Limb Spasticity in Adult Post-Stroke Patients
Query!
Secondary ID [1]
0
0
A-9B-52120-097
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Cerebrovascular Accident
0
0
Query!
Muscle Spasticity
0
0
Query!
Condition category
Condition code
Musculoskeletal
0
0
0
0
Query!
Other muscular and skeletal disorders
Query!
Neurological
0
0
0
0
Query!
Other neurological disorders
Query!
Stroke
0
0
0
0
Query!
Haemorrhagic
Query!
Stroke
0
0
0
0
Query!
Ischaemic
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Other interventions - Botulinum toxin type A
Treatment: Drugs - Placebo
Experimental: Dysport -
Placebo Comparator: Placebo -
Other interventions: Botulinum toxin type A
Treatment: Drugs: Placebo
Query!
Intervention code [1]
0
0
Other interventions
Query!
Intervention code [2]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Change in quality of life measured using the Assessment of Quality of Life questionnaire (12 question version).
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
Query!
Secondary outcome [1]
0
0
Change in muscle spasticity assessed on Modified Ashworth Scale (MAS)
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
Query!
Secondary outcome [2]
0
0
Change in the Modified Motor Assessment Scale
Query!
Assessment method [2]
0
0
Query!
Timepoint [2]
0
0
Query!
Secondary outcome [3]
0
0
Change in patient disability and carer burden rating scale total score
Query!
Assessment method [3]
0
0
Query!
Timepoint [3]
0
0
Query!
Secondary outcome [4]
0
0
Achievement of the patient identified functional outcome measures (Goal Attainment Scaling)
Query!
Assessment method [4]
0
0
Query!
Timepoint [4]
0
0
Query!
Secondary outcome [5]
0
0
Change in the degree of pain
Query!
Assessment method [5]
0
0
Query!
Timepoint [5]
0
0
Query!
Secondary outcome [6]
0
0
Change in depression rating scale total score
Query!
Assessment method [6]
0
0
Query!
Timepoint [6]
0
0
Query!
Secondary outcome [7]
0
0
Global assessment of benefit
Query!
Assessment method [7]
0
0
Query!
Timepoint [7]
0
0
Query!
Eligibility
Key inclusion criteria
- The patient has suffered a stroke, as defined by the World Health Organisation (WHO)
criteria, at least 6 months previously.
- The patient has a hemiparetic arm and meets minimum score requirements on the Modified
Ashworth Scale.
- The patient has the cognitive and communication ability to participate in the study.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- Patients who have received botulinum toxin treatment within the past 120 days.
- Contraindication to botulinum toxin treatment.
- Patients who are receiving oral anti-spasticity medication and who have had a change
in dosage of this medication in the month prior to study entry.
- Patients who have previously been treated with phenol for their upper limb spasticity.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/11/2004
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
20/07/2006
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
96
Query!
Recruitment in Australia
Recruitment state(s)
NSW,VIC
Query!
Recruitment hospital [1]
0
0
St Josephs Hospital - Auburn
Query!
Recruitment hospital [2]
0
0
Royal Prince Alfred Hospital - Camperdown
Query!
Recruitment hospital [3]
0
0
Prince of Wales Hospital - Randwick
Query!
Recruitment hospital [4]
0
0
Box Hill Hospital - Box Hill
Query!
Recruitment hospital [5]
0
0
Caulfield General Medical Centre - Caulfield
Query!
Recruitment hospital [6]
0
0
Austin Health - Heidelberg
Query!
Recruitment postcode(s) [1]
0
0
2144 - Auburn
Query!
Recruitment postcode(s) [2]
0
0
2050 - Camperdown
Query!
Recruitment postcode(s) [3]
0
0
2031 - Randwick
Query!
Recruitment postcode(s) [4]
0
0
3128 - Box Hill
Query!
Recruitment postcode(s) [5]
0
0
3162 - Caulfield
Query!
Recruitment postcode(s) [6]
0
0
3084 - Heidelberg
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Query!
Name
Ipsen
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The main purpose of this study is to assess the effect on Quality of Life of two cycles of
Dysport treatment on post-stroke spasticity of the upper limb. The effect of treatment on
spasticity and function will also be measured.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT00216411
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Ipsen Medical Director
Query!
Address
0
0
Ipsen
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT00216411
Download to PDF